These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9012204)

  • 1. [Specific immunotherapy in allergies--evaluation of current status].
    Jarisch R; Hemmer W
    Wien Med Wochenschr; 1996; 146(15):422-5. PubMed ID: 9012204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyposensitization].
    Przybilla B; Ring J
    Internist (Berl); 1991 Oct; 32(10):606-11. PubMed ID: 1761393
    [No Abstract]   [Full Text] [Related]  

  • 3. [New concepts in therapy of type I allergic diseases].
    Valenta R; Steinberger P; Vrtala S; Grote M; Laffer S; Sperr WR; Valent P; Kraft D; Scheiner O
    Wien Klin Wochenschr; 1993; 105(23):682-6. PubMed ID: 7508663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection.
    Kleine-Tebbe J
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological mechanisms operative in allergen-specific immunotherapy.
    Ebner C
    Int Arch Allergy Immunol; 1999 May; 119(1):1-5. PubMed ID: 10341314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for inhalant allergies. Guidelines for why, when, and how to use this treatment.
    Portnoy JM
    Postgrad Med; 2001 May; 109(5):89-90, 93-4, 99-100 passim. PubMed ID: 11381673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study.
    Holt PG; Sly PD; Sampson HA; Robinson P; Loh R; Lowenstein H; Calatroni A; Sayre P
    J Allergy Clin Immunol; 2013 Oct; 132(4):991-3.e1. PubMed ID: 23768574
    [No Abstract]   [Full Text] [Related]  

  • 8. Broad perspectives of allergen specific immunotherapy.
    Thomas WR
    Hum Vaccin Immunother; 2017 Oct; 13(10):2385-2389. PubMed ID: 28933669
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of antigen-specific immunotherapy of allergy.
    Valenta R
    Nat Rev Immunol; 2002 Jun; 2(6):446-53. PubMed ID: 12093011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyposensitization in general practice. A strategic concept].
    Jorde W
    HNO; 1995 Dec; 43(12):741-4. PubMed ID: 8582837
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergen-specific immunotherapy: is it vaccination against toxins after all?
    Bachmann MF; Kündig TM
    Allergy; 2017 Jan; 72(1):13-23. PubMed ID: 27558586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with allergens.
    Creticos PS; Norman PS
    JAMA; 1987 Nov; 258(20):2874-80. PubMed ID: 3312669
    [No Abstract]   [Full Text] [Related]  

  • 13. Histamine receptors in immune regulation and allergen-specific immunotherapy.
    Jutel M; Blaser K; Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):245-59, vii. PubMed ID: 16701143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy.
    Larenas-Linnemann DE
    Allergy Asthma Proc; 2008; 29(2):130-9. PubMed ID: 18430309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of immunotherapy with individual allergens: Immunotherapy with fungi.
    Pineda F
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():36-38. PubMed ID: 29129403
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of immunotherapy delivery methods for allergen immunotherapy.
    Klimek L; Pfaar O
    Expert Rev Clin Immunol; 2013 May; 9(5):465-74; quiz 475. PubMed ID: 23634740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy in pediatrics using Allpyral antigens (clinical effectiveness)].
    Pérez Martín J; Moreno MA; Valdovinos Avilés H; Madariaga Márquez JB
    Alergia; 1982 Oct; 29(4):111-21. PubMed ID: 7165066
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in patent applications related to allergen immunotherapy.
    Silva ES; Pinheiro CS; Quintella CM; Ferreira F; C Pacheco LG; Alcântara-Neves NM
    Expert Opin Ther Pat; 2016 Jun; 26(6):657-68. PubMed ID: 27011299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyposensitization: indications and expectations].
    Urbanek R
    Padiatr Padol; 1990; 25(6):397-404. PubMed ID: 2080061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.